Restart guidance

The COVID-19 pandemic resulted in Trust research teams being redeployed to support the COVID-19 research and front-line clinical services. This impacted vital research and centres needed to plan a phased restart of experimental cancer studies, prioritising the safety of patients and staff and aligning with the NIHR Restart Framework.

Based on experiences and approaches from across the ECMC network the CBLs worked collaboratively to produce guidance on what to consider when reviewing and making improvements to local restart frameworks to set-up, open and recruit to trials during national emergencies. This document can be used by members of the network to help implement or improve restart prioritisation categorisation of trials.